Decline in circulating viral and human tumor markers after resection of head and neck carcinoma.
Erin M LopezApril Michelle TannerEugenie DuSamip N PatelJared WeissMark C WeisslerTrevor HackmanGaorav P GuptaJose P ZevallosSandra ElmoreRenee BetancourtLeigh ThorneSiddharth ShethMargaret L GulleyPublished in: Head & neck (2020)
Modern sequencing technology can simultaneously quantify human gene variants and oncogenic viral genomes in plasma. Falling levels of cancer-specific markers upon resection can help identify viral and human markers to track at subsequent timepoints as a means to evaluate efficacy of interventions.